Akazawa Starts 8th U.S. Visit for Tariff Talks
HEADLINES Washington, July 21 (Jiji Press)–Japan’s economic revitalization minister Ryosei Akazawa on Monday kicked off his eighth visit to the United States for...
5 Ex&SMBC Nikko Officials Convicted in Market Manipulation Case
HEADLINES Tokyo, July 22 (Jiji Press)–Tokyo District Court on Tuesday found five former senior officials of SMBC Nikko Securities Inc. guilty in a...
Lutovinov Appointed Ukrainian Ambassador to Japan
HEADLINES Tokyo, July 22 (Jiji Press)–Ukrainian President Volodymyr Zelenskyy has appointed Yuriy Lutovinov, former minister-counselor at the Ukrainian Embassy in Japan, as ambassador...
CDP's Noda Seeks to Deepen Ties within Opposition Camp
HEADLINES Tokyo, July 22 (Jiji Press)–Constitutional Democratic Party of Japan leader Yoshihiko Noda indicated Tuesday that the main opposition party will seek to...
Kansai Electric to Survey Fukui Pref. Site for New Reactor
HEADLINES Osaka, July 22 (Jiji Press)–Kansai Electric Power Co. said Tuesday it will conduct topographical and geological surveys in the town of Mihama...
Ishiba Remark on Reducing Dependence on U.S. Not Problem: Rubio
HEADLINES Kuala Lumpur, July 12 (Jiji Press)–U.S. Secretary of State Marco Rubio has said that he does not take issue with Japanese Prime...
Jiji Press Employee Nabbed for Alleged Theft
HEADLINES Tokyo, July 10 (Jiji Press)–Tokyo’s Metropolitan Police Department has arrested a 34-year-old male employee of Jiji Press Ltd. on suspicion of theft,...
Japan to Tighten Rules for Foreigners' Driving License Switch
HEADLINES Tokyo, July 10 (Jiji Press)–Japan’s National Police Agency on Thursday unveiled a draft proposal to oblige foreigners to submit in principle residence...
2025 POLLS: Japanese Parties Divided on Defense Spending Increase
HEADLINES Tokyo, July 9 (Jiji Press)–Major Japanese political parties call for boosting the country’s defense capabilities in their campaigns for the July 20...
Japan to Cut Price of Alzheimer's Drug Lecanemab
HEADLINES Tokyo, July 10 (Jiji Press)–Japan is expected to lower the price of lecanemab, an Alzheimer’s drug codeveloped by Japanese drugmaker Eisai Co....